Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial

2011 ◽  
Vol 2011 ◽  
pp. 221-222
Author(s):  
B.J. Gersh
Sign in / Sign up

Export Citation Format

Share Document